Sharpless elected to Association of American Cancer Institutes’ Board

UNC Lineberger Comprehensive Cancer Center Director Norman E. Sharpless, MD, has won election to the Association of American Cancer Institutes’ Board of Directors.

Sharpless elected to Association of American Cancer Institutes’ Board click to enlarge UNC Lineberger Director Norman E. Sharpless, MD, has been elected to the AACI's Board of Directors

UNC Lineberger Comprehensive Cancer Center Director Norman E. Sharpless, MD, has won election to the Association of American Cancer Institutes’ Board of Directors. He will start his three-year term during the AACI/Cancer Center Administrators Forum’s annual meeting in Chicago, Oct. 23-15.

AACI was founded to reduce the burden of cancer by enhancing the impact of the leading academic cancer centers in the U.S. and Canada. AACI facilitates interaction among its 95 member centers, educates policy makers, and fosters the development of partnerships between cancer centers and other cancer organizations to improve the overall quality of cancer care.

Sharpless is the Wellcome Distinguished Professor of Cancer Research and a professor of medicine and genetics at UNC School of Medicine. He is recognized for his work in cancer biology and genomics, and specifically for advancing the science of biomarkers, aging and cancer, and novel therapeutic approaches. He has authored more than 130 reports, reviews and book chapters, holds 14 filed or issued patents and has co-founded two Research Triangle Park start-up companies.

He is on the scientific advisory board of several research foundations, serves as an editor of the Journal of Clinical Investigation and Aging Cell, and is an elected member of the American Society of Clinical Investigators and the Association of American Physicians.

As part of its mission, AACI gathers and shares best practices among cancer centers, providing a forum for its members to address common challenges and explore new opportunities, supporting initiatives that engage the membership in developing specific recommendations to the National Cancer Institute, and educating policy makers about the important role cancer centers play in advancing cancer discovery.